Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Automated high-resolution computed tomography analysis outperforms visual assessment in predicting interstitial lung disease progression in systemic sclerosis.

Rheumatology (Oxford, England)·2026

Same author

Clinical impact of mucus plugs in bronchiectasis.

Scientific reports·2026

Same author

Inflammatory endotypes in immunocompromised patients with community-acquired pneumonia: a framework for treatable traits.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Same author

Bronchiectasis in Italy: an analysis of the EMBARC registry.

ERJ open research·2026

Same author

Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospital.

Antimicrobial resistance and infection control·2026

Same author

Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature.

ERJ open research·2026

Search research articles

Related Experiment Video

Updated: May 29, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Global Variation in Pneumonia Epidemiology.

Margherita S Silani¹, Anna Stainer², Francesco Amati²

¹Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; IRCCS Humanitas Research Hospital, Respiratory Unit, Via Manzoni 56, 20089, Rozzano, Milan, Italy; Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Clinics in Chest Medicine

|May 27, 2026

Summary

Pneumonia remains a major global health threat, causing over 2 million deaths in 2021. Understanding its epidemiology, risk factors, and antibiotic resistance is key to reducing its worldwide impact.

Keywords:

Epidemiology Global health Pneumonia Respiratory infections Risk factors

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Experiment Videos

Last Updated: May 29, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Area of Science:

Public Health
Epidemiology
Infectious Diseases

Background:

Pneumonia is a persistent global public health challenge.
Despite declines in lower respiratory tract infections, pneumonia caused over 2 million deaths in 2021.
Significant global disparities exist in pneumonia's impact.

Purpose of the Study:

To examine global disparities in pneumonia epidemiology.
To analyze trends in pneumonia incidence and mortality.
To explore the influence of risk factors, prevention, microbiology, and antibiotic resistance on pneumonia burden.

Main Methods:

Review of global pneumonia epidemiology data.
Analysis of incidence and mortality trends.
Examination of risk and preventive factors.
Assessment of microbiological dynamics and antibiotic resistance.

Main Results:

Pneumonia incidence and mortality vary significantly worldwide.
Risk and preventive factors play a crucial role in pneumonia burden.
Microbiological factors and rising antibiotic resistance complicate control efforts.

Conclusions:

Targeted strategies are essential to reduce the global burden of pneumonia.
Addressing epidemiological, microbiological, and resistance factors is critical for public health.
Enhanced public health outcomes depend on comprehensive pneumonia control measures.